{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"app-related-brain-and-vascular-amyloidosis","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A hereditary amyloidosis characterized by a spectrum of neurodegenerative and neurovascular phenotypes caused by pathogenic variant in the APP gene, resulting in an abnormal clearance of amyloid peptides, either by overproduction and decreased clearance of amyloid peptides, with deposition of amyloid in plaques and blood vessel walls. Affected individuals may present with progressive cognitive decline, cerebral vascular amyloidosis with white matter changes, and stroke with or without hemorrhage.","mondoId":"MONDO:1060190","node":{"canonicalSlug":"app-related-brain-and-vascular-amyloidosis","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"APP-related brain and vascular amyloidosis","paragraphs":["A hereditary amyloidosis characterized by a spectrum of neurodegenerative and neurovascular phenotypes caused by pathogenic variant in the APP gene, resulting in an abnormal clearance of amyloid peptides, either by overproduction and decreased clearance of amyloid peptides, with deposition of amyloid in plaques and blood vessel walls. Affected individuals may present with progressive cognitive decline, cerebral vascular amyloidosis with white matter changes, and stroke with or without hemorrhage."],"scope":"exact","source":"MONDO","upstream":"https://clinicalgenome.org/affiliation/40156/","url":"https://monarchinitiative.org/MONDO:1060190"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"cerebrovascular disorder","mondoId":"MONDO:0011057","slug":null},{"kind":"parent","label":"hereditary amyloidosis","mondoId":"MONDO:0018634","slug":"hereditary-amyloidosis"},{"kind":"parent","label":"inherited neurodegenerative disorder","mondoId":"MONDO:0024237","slug":"inherited-neurodegenerative-disorder"},{"kind":"child","label":"Alzheimer disease type 1","mondoId":"MONDO:0007088","slug":"alzheimer-disease-type-1"},{"kind":"child","label":"cerebral amyloid angiopathy, APP-related","mondoId":"MONDO:0011583","slug":"cerebral-amyloid-angiopathy-app-related"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/28185"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:1060190\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://clinicalgenome.org/affiliation/40156/</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A hereditary amyloidosis characterized by a spectrum of neurodegenerative and neurovascular phenotypes caused by pathogenic variant in the APP gene, resulting in an abnormal clearance of amyloid peptides, either by overproduction and decreased clearance of amyloid peptides, with deposition of amyloid in plaques and blood vessel walls. Affected individuals may present with progressive cognitive decline, cerebral vascular amyloidosis with white matter changes, and stroke with or without hemorrhage.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:1060190\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"app-related-brain-and-vascular-amyloidosis","sourceDocuments":[{"name":"MONDO: APP-related brain and vascular amyloidosis","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:1060190"}],"sourceNote":"","synonyms":["APP-related brain and vascular amyloidosis"],"takeawayHtml":"","title":"APP-related brain and vascular amyloidosis"},"schemaVersion":1}
